EOLS - CIK 0001570562
The table below shows Evolus, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $53.83M | $86.95M | $62.84M | $53.92M | $146.26M | $102.56M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $54.70M | $47.68M | $30.53M | $22.45M | $14.66M | $9.68M |
| Inventory | $26.96M | $12.16M | $11.00M | $18.85M | $1.76M | $3.35M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $142.92M |
| $151.34M |
| $112.42M |
| $100.80M |
| $178.80M |
| $127.61M |
| Property, plant & equipment | $5.37M | $3.22M | $2.09M | $2.62M | $1.37M | $1.30M |
| Goodwill | $21.21M | $21.21M | $21.21M | $21.21M | $21.21M | $21.21M |
| Total assets | $225.87M | $232.57M | $189.00M | $177.98M | $257.48M | $209.07M |
| Accounts payable | $23.36M | $9.24M | $4.27M | $8.94M | $6.09M | $9.62M |
| Total current liabilities | $75.31M | $62.96M | $48.29M | $46.51M | $57.66M | $180.25M |
| Long-term debt | $146.10M | $121.51M | $120.36M | $71.88M | $71.22M | - |
| Total liabilities | $248.97M | $227.05M | $209.69M | $159.48M | $175.61M | $282.03M |
| Retained earnings | -$661.04M | -$609.40M | -$558.98M | -$497.29M | -$422.88M | -$376.07M |
| Total equity | -$23.11M | $5.52M | -$20.69M | $18.50M | $81.88M | -$72.96M |